Ambu A/S (LON:0MJF)
87.85
-0.15 (-0.17%)
At close: Dec 23, 2025
Ambu A/S Revenue
In the fiscal year ending September 30, 2025, Ambu A/S had annual revenue of 6.04B DKK with 11.98% growth. Ambu A/S had revenue of 1.47B in the quarter ending September 30, 2025, with 5.70% growth.
Revenue
6.04B DKK
Revenue Growth
+11.98%
P/S Ratio
3.90
Revenue / Employee
1.12M DKK
Employees
5,384
Market Cap
2.75B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 6.04B | 646.00M | 11.98% |
| Sep 30, 2024 | 5.39B | 616.00M | 12.90% |
| Sep 30, 2023 | 4.78B | 331.00M | 7.45% |
| Sep 30, 2022 | 4.44B | 431.00M | 10.74% |
| Sep 30, 2021 | 4.01B | 446.00M | 12.50% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |